Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows Revision: v3.6.6. This indicates a new version of the study record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4 revision tag. This indicates the page was updated to a newer revision.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision indicator updated from Revision: v3.6.3 to Revision: v3.6.4. This change signals a newer build of the site's page rendering, likely a minor maintenance update to the page template or underlying platform.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page version tag was upgraded from v3.6.2 to v3.6.3, signaling a small update to the page’s version without indicating changes to the study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision stamp was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study page. This appears to reflect maintenance or QC updates rather than changes to study details or outcomes.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating no participants are being sought. It also standardizes the Intervention/Treatment label and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.